Medicenna Therapeutics (MDNA) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Understanding Accounting and Bookkeeping Services for Business Success

June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success

Every successful business relies on accurate financial records. From managing cash flow to ensuring compliance with tax regulations, reliable accounting and bookkeeping services…
How much does a Turkish passport cost?

May 27, 2025 How much does a Turkish passport cost?

Turkish citizenship comes with numerous benefits. Once granted, a foreigner can enter 126 countries visa-free, enjoy high-quality healthcare and favorable tax regimes, and…
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…
Are you making these mistakes when analyzing candlestick patterns?

May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?

Trading is a very popular endeavor these days, and for good reason, as it is widely accessible and allows individuals to generate additional…
Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…

Medicenna Therapeutics (MDNA) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: June 18, 2025 (13:17)

Sector: Healthcare

The share price of Medicenna Therapeutics Corp. (MDNA) now

This company is DELISTED
Latest session on the 18th of June for
Medicenna Therapeutics Corp. is negative
Trading Volume:
Open: 0 /  High: 0 /  Low: 0

Are you interested in Medicenna Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Medicenna Therapeutics stock price in 2025, 2026, 2027. How much will one Medicenna Therapeutics share be worth in 2025 - 2027?

When should I take profit in Medicenna Therapeutics stock? When should I record a loss on Medicenna Therapeutics stock? What are analysts' forecasts for Medicenna Therapeutics stock? What is the future of Medicenna Therapeutics stock? We forecast Medicenna Therapeutics stock performance using neural networks based on historical data on Medicenna Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Medicenna Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Medicenna Therapeutics shares. This happens once a day.


Historical and forecast chart of Medicenna Therapeutics stock

The chart below shows the historical price of Medicenna Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Medicenna Therapeutics stock price can be found in the table below.

No data

Long-term forecasts by years.

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.

Trending Themes in the Healthcare Sector

Medicenna Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 20 0.37 0.36 0.38 5.90
Jun 21 0.37 0.36 0.37 3.81
Jun 22 0.37 0.36 0.38 5.61
Jun 23 0.37 0.37 0.38 4.42
Jun 24 0.38 0.37 0.38 4.07
Jun 25 0.39 0.38 0.39 4.04
Jun 26 0.39 0.38 0.40 4.57
Jun 27 0.39 0.39 0.40 3.59
Jun 28 0.38 0.37 0.39 4.83
Jun 29 0.37 0.36 0.38 3.82
Jun 30 0.37 0.36 0.37 2.60
Jul 01 0.37 0.36 0.37 2.31
Jul 02 0.37 0.37 0.38 2.77
Jul 03 0.37 0.37 0.38 3.33
Jul 04 0.37 0.36 0.38 4.29
Jul 05 0.38 0.37 0.38 4.74
Jul 06 0.39 0.38 0.40 5.66
Jul 07 0.40 0.39 0.40 3.15
Jul 08 0.41 0.40 0.41 3.33
Jul 09 0.40 0.39 0.41 5.10
Jul 10 0.40 0.39 0.41 5.69
Jul 11 0.38 0.38 0.40 4.43
Jul 12 0.40 0.39 0.40 3.07
Jul 13 0.41 0.40 0.41 2.59
Jul 14 0.40 0.40 0.41 3.55
Jul 15 0.42 0.41 0.43 4.43
Jul 16 0.40 0.39 0.41 4.08
Jul 17 0.39 0.38 0.40 4.22
Jul 18 0.38 0.38 0.39 2.81
Jul 19 0.38 0.38 0.39 2.39

Medicenna Therapeutics Daily Price Targets


Medicenna Therapeutics Stock Forecast 06-20-2025.

Forecast target price for 06-20-2025: $0.37.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 5.575%.
Pessimistic target level: 0.36
Optimistic target level: 0.38

Medicenna Therapeutics Stock Forecast 06-21-2025.

Forecast target price for 06-21-2025: $0.37.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 3.666%.
Pessimistic target level: 0.36
Optimistic target level: 0.37

Medicenna Therapeutics Stock Forecast 06-22-2025.

Forecast target price for 06-22-2025: $0.37.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 5.308%.
Pessimistic target level: 0.36
Optimistic target level: 0.38

Medicenna Therapeutics Stock Forecast 06-23-2025.

Forecast target price for 06-23-2025: $0.37.
Negative dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 4.229%.
Pessimistic target level: 0.37
Optimistic target level: 0.38

Medicenna Therapeutics Stock Forecast 06-24-2025.

Forecast target price for 06-24-2025: $0.38.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 3.911%.
Pessimistic target level: 0.37
Optimistic target level: 0.38

Medicenna Therapeutics Stock Forecast 06-25-2025.

Forecast target price for 06-25-2025: $0.39.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 3.884%.
Pessimistic target level: 0.38
Optimistic target level: 0.39

MDNA (MDNA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jul. 0.35 0.33 0.37 11.64
Jul. 0.37 0.34 0.42 18.43
Aug. 0.35 0.34 0.39 13.64
Oct. 0.29 0.25 0.32 23.89
Oct. 0.28 0.25 0.32 20.19
Dec. 0.30 0.28 0.32 12.62
Dec. 0.29 0.25 0.33 23.29

Medicenna Therapeutics forecast for this year


Medicenna Therapeutics Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $0.347282. Pessimistic: $0.33. Optimistic: $0.37


Medicenna Therapeutics Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $0.374335. Pessimistic: $0.34. Optimistic: $0.42


Medicenna Therapeutics Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $0.348731. Pessimistic: $0.34. Optimistic: $0.39


Medicenna Therapeutics Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $0.28711. Pessimistic: $0.25. Optimistic: $0.32


Medicenna Therapeutics Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $0.2822. Pessimistic: $0.25. Optimistic: $0.32


Medicenna Therapeutics Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $0.298286. Pessimistic: $0.28. Optimistic: $0.32


Medicenna Therapeutics Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $0.292618. Pessimistic: $0.25. Optimistic: $0.33



Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.30 0.28 0.32 10.69
Mar 0.31 0.28 0.35 20.59
Mar 0.35 0.32 0.36 11.67
May 0.34 0.32 0.36 12.04
May 0.29 0.25 0.32 22.85
Jul 0.30 0.28 0.33 14.83
Jul 0.31 0.28 0.35 19.99
Aug 0.29 0.28 0.32 14.40
Oct 0.30 0.27 0.33 18.75
Oct 0.27 0.24 0.29 16.24
Dec 0.30 0.28 0.31 9.09
Dec 0.30 0.27 0.32 16.16

Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.26 0.23 0.30 20.85
Mar 0.22 0.19 0.24 19.99
Mar 0.22 0.19 0.23 18.32
May 0.22 0.21 0.23 10.07
May 0.23 0.22 0.25 15.00
Jul 0.22 0.20 0.24 13.87
Jul 0.25 0.24 0.27 11.37
Aug 0.26 0.22 0.28 21.92
Oct 0.25 0.23 0.28 18.42
Oct 0.21 0.19 0.24 18.98
Dec 0.19 0.17 0.21 22.92
Dec 0.17 0.16 0.19 11.50

Medicenna Therapeutics information and performance

Medicenna Therapeutics Address

N/A

Market Capitalization: N/A $

Market capitalization of the Medicenna Therapeutics Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MDNA shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Medicenna Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Medicenna Therapeutics Stock)

Should I Buy Medicenna Therapeutics Shares in 2025 year?

The maximum forecasted share price for next year is $0.35, Это на 0.01$ меньше чем текущая цена акций. Инвестируя сегодня в акции Medicenna Therapeutics на срок 1 год вы получите убыток в размере 3.13%. With an investment horizon of up to two years, the target share price is 0.26$. Убыток: 28.43% (-0.10$ на каждую акцию).

Does Medicenna Therapeutics pay dividends?

No, it does not

Which economic sector do Medicenna Therapeutics's shares belong to?

Medicenna Therapeutics's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Medicenna Therapeutics's shares?

You can view all the stocks that are part of the same sector as Medicenna Therapeutics's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.